Voyageur Pharmaceuticals Ltd
XTSX:VM

Watchlist Manager
Voyageur Pharmaceuticals Ltd Logo
Voyageur Pharmaceuticals Ltd
XTSX:VM
Watchlist
Price: 0.13 CAD -7.14% Market Closed
Market Cap: CA$23.2m

Profitability Summary

Voyageur Pharmaceuticals Ltd's profitability score is 10/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

10/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

10/100
Profitability
Score
10/100
Profitability
Score

Margins

Earnings Waterfall
Voyageur Pharmaceuticals Ltd

Margins Comparison
Voyageur Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Voyageur Pharmaceuticals Ltd
XTSX:VM
23.2m CAD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
856.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
566.8B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
362.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
243.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.4B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
282.6B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.2B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Voyageur Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Voyageur Pharmaceuticals Ltd
XTSX:VM
23.2m CAD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
856.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
566.8B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
362.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
243.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
282.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.2B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Voyageur Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett